Share on StockTwits

Hologic (NASDAQ:HOLX) was downgraded by analysts at Barrington Research from an “outperform” rating to a “market perform” rating in a research report issued to clients and investors on Tuesday, TheFlyOnTheWall.com reports.

Hologic (NASDAQ:HOLX) traded down 0.77% during mid-day trading on Tuesday, hitting $25.66. The stock had a trading volume of 1,589,654 shares. Hologic has a one year low of $19.25 and a one year high of $26.75. The stock has a 50-day moving average of $25.51 and a 200-day moving average of $23.06. The company’s market cap is $7.127 billion.

Hologic (NASDAQ:HOLX) last posted its quarterly earnings results on Wednesday, July 30th. The company reported $0.37 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.34 by $0.03. The company had revenue of $632.60 million for the quarter, compared to the consensus estimate of $621.89 million. During the same quarter in the previous year, the company posted $0.38 earnings per share. The company’s revenue for the quarter was up 1.0% on a year-over-year basis. Analysts expect that Hologic will post $1.45 EPS for the current fiscal year.

A number of other firms have also recently commented on HOLX. Analysts at JPMorgan Chase & Co. reiterated an “overweight” rating on shares of Hologic in a research note on Thursday, July 31st. They now have a $31.00 price target on the stock, up previously from $28.00. Separately, analysts at SunTrust reiterated a “r” rating on shares of Hologic in a research note on Thursday, July 31st. They now have a $18.00 price target on the stock, up previously from $15.00. Finally, analysts at ISI Group raised their price target on shares of Hologic from $27.00 to $29.00 in a research note on Wednesday, July 9th. One investment analyst has rated the stock with a sell rating, twelve have assigned a hold rating and four have issued a buy rating to the company. The stock presently has a consensus rating of “Hold” and a consensus target price of $24.50.

Hologic, Inc is a developer, manufacturer and supplier of diagnostics products, medical imaging systems and surgical products to serving the healthcare needs of women.

The Fly On The Wall

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.